Subjective Visual Vertical Test Has Low Sensitivity for Identifying Meniere Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 2, 2024 -- The subjective visual vertical (SVV) test has relatively low sensitivity for diagnosing Meniere disease, according to a study published in the July and August issue of the Iranian Journal of Otorhinolaryngology.
Hadi Behzad, Ph.D., from the Shahid Beheshti University of Medical Science in Tehran, Iran, and colleagues conducted a study on 53 patients with confirmed unilateral Meniere disease and a control group to examine use of the SVV test in static and dynamic models as well as the electrocochleography (ECochG) test for diagnosing Meniere disease.
The researchers found that the optimal cutoff point obtained for the tilt toward the lesion was 2.1 degrees of deviation, which had sensitivity of 0.698 and specificity of 0.717. This was identified as the best condition for differentiating individuals with Meniere disease from the healthy control group, but the levels of sensitivity and specificity were considered relatively low for an auditory test and unreliable in terms of diagnosis.
"Based on the current findings, the SVV test has relatively low sensitivity for diagnosing Meniere's disease. Therefore, relying solely on its results to identify Meniere's disease is not recommended," the authors write. "Future studies should explore other avenues besides using ECochG and SVV tests together."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Study Compares Benefits, Harms of Treatments for Chronic Hives
WEDNESDAY, July 23, 2025 -- Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study...
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Endocrine Society, July 12-15
The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.